Scinderin Antikörper (AA 556-703) (HRP)
-
- Target Alle Scinderin (SCIN) Antikörper anzeigen
- Scinderin (SCIN)
-
Bindungsspezifität
- AA 556-703
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Scinderin Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Adseverin protein (556-703AA)
- Isotyp
- IgG
- Top Product
- Discover our top product SCIN Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- Scinderin (SCIN)
- Andere Bezeichnung
- SCIN (SCIN Produkte)
- Hintergrund
-
Background: Ca(2+)-dependent actin filament-severing protein that is presumed to have a regulatory function in exocytosis by affecting the organization of the microfilament network underneath the plasma membrane. In vitro, also has barbed end capping and nucleating activities in the presence of Ca(2+). Regulates chondrocyte proliferation and differentiation. MAP kinases p38 and ERK1/2 mediate the adseverin-induced accelerated differentiation of non-hypertrophic chondrocytes (By similarity).
Aliases: Adseverin antibody, ADSV_HUMAN antibody, KIAA1905 antibody, Scin antibody, Scinderin antibody
- UniProt
- Q9Y6U3
- Pathways
- Regulation of Actin Filament Polymerization
-